• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    A randomized, controlled trial of Shutangluo fang in treating painful diabetic peripheral neuropathy

    2016-03-27 07:41:46DiHongjie狄紅杰ChuXiaoqiu褚曉秋LiuKemian劉克冕andLiuChao劉超
    關(guān)鍵詞:劉超

    Di Hongjie(狄紅杰), Chu Xiaoqiu(褚曉秋), Liu Kemian(劉克冕), and Liu Chao(劉超)

    Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210028, China

    A randomized, controlled trial of Shutangluo fang in treating painful diabetic peripheral neuropathy

    Di Hongjie(狄紅杰), Chu Xiaoqiu(褚曉秋), Liu Kemian(劉克冕), and Liu Chao(劉超)*

    Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210028, China

    OBJECTIVE:To assess efficacy of Shutangluo fang on painful diabetic peripheral neuropathy(PDPN).

    Painful diabetic peripheral neuropathy; Shutangluo fang; Epalrestat

    Painful diabetic peripheral neuropathy (PDPN) is one of the common chronic complications of diabetes,which are often associated with considerable morbidity and mortality. It requires medical attention because of its adverse effects on quality of life1. There are many treatment options available include anticonvulsants, antidepressants, opioids and others2. But there are problems of side-effects and contraindications for all these drugs3. Thus, the development of new drugs to manage PDPN remains a high priority.

    Shutangluo fang, which has been long used as an anti-diabetes medicine in our department, proved to be effective on diabetic peripheral neuropathy (DPN). This study evaluated the efficacy of Shutangluo fang in relieving PDPN.

    METHODS

    Overview

    This was a randomized, placebo-controlled, parallel-group study. Eighty-two patients with PDPN were invited to participate in this clinical trial starting from July 2013 to May 2016 at endocrine and diabetes center of Jiangsu Province Hospital on Integration of Chinese and Western Medicine. The patients were composed of 46 men and 34 women, with the mean age of 56.54±7.82 years. Each patient read and signed informed consent before initiating any study procedures.

    Selection criteria

    All the patients enrolled in the study should meet the diagnostic criteria for PDNP issued by Chinese Diabetes Society (CDS)4. The criteria mainly include:① Diabetes for at least 3 months on stable dosage of oral hypoglycemic agent or insulin.②Daily neuropathic pain of at least moderate severity for more than 3 months.③Written consent to participate in the study.

    Exclusion criteria

    Patients with hemoglobin A1c levels of more than 11% were excluded, as were patients with clinically significant or unstable liver, hematologic, or respiratory illnesses, vitamin def i ciency, symptomatic peripheral vascular disease, or unstable cardiovascular disease.

    Study design

    All patients were divided into the control group (CG) and Shutangluo fang treatment group (STG) randomly. Both groups recieved conventional therapy (diet treatment, hypoglycemic agents, insulin, and hypotensive agents) and held constant throughout the study. Adequate glucose control was maintained to ensure patient safety. Epalrestat (50 mg) was orally administered three times daily before each meal (150 mg/day) for each patient. The patients in treatment group received Shutangluo fang, which composed of euonymus alatus, trumpetcreeper, rehmannia,rhizoma coptidis and radix puerariae lobatae. The course of treatment lasts for 3 months.

    Laboratory studies

    All patients were subjected to thorough interview, clinical examination and relevant laboratory investigations. All of them were asked to fill in (by themselves or with assistance) visual analogue score (VAS) first initially, then after 3 months. Biochemical examinations, which included fasting blood glucose (FBG), HbA1c, lipid prof i le was done at the beginning of the study and after 3 months. Electrophysiological studies, in the form of sensory nerve conduction studies (SNCV), were performed at the beginning of the study and after 3 months in both groups.

    Efficacy measures

    The primary efficacy measure for this study was the reduction in mean of the 24-hour average pain scores (computed from diary scores between two site visits), as measured by an 11-point (0 = no pain, 10 = worst possible pain) Likert scale that was completed daily by the patients in a diary. We considered a reduction difference more than 30% a significant effect, from 15% to 30% in an insignif i cant ef f ect, and less than 15% in no ef f ect5.

    Statistical analysis

    All statistical testing were two-sided and performed using SAS procedures. All values (e.g. HbA1c) were expressed as means ± SD. Statistical methods used includedx2tests for nominal scale, two-sample tests for comparison of mean values between groups. Values were adjusted using the Hochberg25 procedure in order to protect the type I error rate at the 0.05 level.

    RESULTS

    Patient disposition, demographics, and disease characteristics

    A total of 82 patients were randomized to the study. The demographics for all patients, 41 patients were treated with epalrestat (CG) and 41 patients were treated with Shutangluo fang with epalrestat (STG), are provided in Table 1. There were no signif i cant dif f erences between two groups.

    Table 1. Selected characteristics of subjects

    Changes in glycemic control and lipid prof i le

    Changes in glycemic control and lipid profile of the patients were followed up for 3 months. In the control group (n= 41), A1C (means ± SD) at baseline and 3 months was (7.71±1.05), and (7.91±1.02)%, respectively. Corresponding values in the Shutangluo fang group (n=41) were (7.82 ± 1.12), and (7.79±1.11)%, respectively. There were no signif i cant dif f erences between the two groups. Also, there were no significant differences in lipid profile between the two groups at any time points (Table 2).

    Table 2. Mean change from baseline to endpoint of HbA1c and lipid pro fi le

    Table 2. Mean change from baseline to endpoint of HbA1c and lipid pro fi le

    FBG: fasting blood glucose; LDL-C: low density lipoprotein cholesterol.HbA1C: glycosylated hemoglobin A1C; TG: total triglyceride;*P>0.05, versus baseline;▲P>0.05,versus control group.

    Parameter Control group Treatment group Baseline EndpointBaseline Endpoint Number(n)4141 FBG(mmol/L)8.58±1.838.49±1.93*8.61±1.928.48±1.95*▲HbA1C(%)7.71±1.057.91±1.02*7.82±1.127.79±1.11*▲LDL-C(mmol/L)2.86±1.192.79±1.12*2.91±1.212.88±0.99*▲TG(mmol/L)1.81±0.811.79±0.88*1.79±0.851.78±0.89*▲

    Change in subjective symptoms

    At baseline, the pain scores based on visual analogue score (VAS) had no significant difference between the two groups (5.73±1.17 VS 5.68±1.19, P>0.05). At the endpoint, both groups signif i cantly reduced pain compared to the baseline. The endpoint mean pain score, was signif i cantly improved by Shutangluo fang when compared to the control group (2.21±0.82 VS 4.13±0.97,P<0.05).

    The proportion of patients achieving a >15% reduction in pain was signif i cantly higher in Shutangluo fang group than the control group (Table 3).

    Table 3. Analysis of the proportion of responders

    Change in sensory nerve conduction velocity(SNCV)

    Table 4 shows each electrophysiological measure (means ± SD) at the baseline and end-of-treatment time points. At baseline, no statistically signif i cant deteriorations in median SNCV were observed in the two groups. The electrophysiological measure of sensory function measures demonstrated signif i cant improvement (P<0.05) over the 3-month treatment period in both groups. At the endpoint, mean SNCV was significantly improved by Shutangluo fang when compared to the control group (P<0.05).

    Table 4. Analysis of the nerve conduction velocity

    Table 4. Analysis of the nerve conduction velocity

    *P<0.05, versus baseline;▲P<0.05, versus control group.

    Median nerveUlnar nerveCommon peroneal nerveTibial nervenBaselineEndpointBaselineEndpointBaselineEndpointBaselineEndpoint Treatment group4135.43±3.55 45.79±4.15*▲34.83±4.02 46.19±3.97*▲33.89±3.85 46.08±4.27*▲34.51±3.95 47.69±4.28*▲Control group4135.75±3.6240.16±4.01*35.02±3.9839.99±3.99*34.09±4.0639.06±4.38*34.28±3.8940.56±4.35*

    DISCUSSION

    Painful diabetic peripheral neuropathy represents a diffuse symmetric and length-dependent injury to patients and it has bad ef f ect on quality of life, morbidity, and costs from a public health perspective6. Although several pivotal trials have shown that strict glycemic control reduces the occurrence and progression of diabetes-related complications, it is difficult to restore nerve function7. So far no ideal drug has been available for its management. In this trial, Shutangluo fang was effective on PDPN.

    As we all know, hyperglycemia-induced hyperactivity of polyol pathway links to the augmentation of the metabolic disorders, like oxidative stress, and others, contributing to the deterioration of diabetic neuropathy. Suppression of this pathway may be an important key to efficient treatment for DPDN. The key enzyme of the polyol pathway is aldose reductase (AR). There are many reports supporting the beneficial effects of AR inhibitors in animal models for diabetic neuropathy and diabetic patients8. In our clinical trial, epalrestat which is the only ARI currently available commercially, is ef f ective on PDPN. But we also fi nd its ef f ect for symptoms (e.g. pain) is poor in clinical practice.

    There is no painful diabetic peripheral neuropathy in terms of traditional Chinese medicine (TCM). However, according to its clinical manifestations, the disease may belong to the categories ofarthralgia zheng. Its etiology and pathogenesis mainly lie in uncontrolled diet or interior injury by seven emotions, which result in extreme heat with yin asthenia and stagnation of blood, failure of the transport nutrients to extremities, ultimately led to the symptoms including pain.

    Many studies have demonstrated the efficacy of Chinese medicine in painful diabetic peripheral neuropathy9. Shutangluo fang is the clinical experienced prescription of our department. Euonymus alatus is the principal drug of Shutangluo fang. Its effects include disintegrating blood stasis and dredging collaterals, eliminating stasis to activate blood circulation and relieve pain. The ministerial drug is trumpetcreeper which is added to strengthen the effects of promoting blood circulationand remove blood stasis. Rehmannia, rhizoma coptidis and radix puerariae lobatae are used to clear away heat, nourishing Yin and cooling blood. The results presented here indicate that Shutangluo fang can relieve the pain and improve the sensory nerve conduction velocity.

    In conclusion, Shutangluo fang is ef f ective on painful diabetic peripheral neuropathy. But we need long-term clinic trial to assess the efficacy and safety of Shutangluo fang in the treatment of painful diabetic neuropathy.

    REFERENCES

    1 Argof f CE, Cole BE, Fishbain DA, et al. Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc,2006(81): S3-S11.

    2 Casandra JR, James CW. Treatment of painful diabetic peripheral neuropathy. Prosthet Orthot Int,2015,39(1):17-28.

    3 Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med,2000(108):2-8.

    4 Chinese Diabetes Society. Guidelines for prevention and treatment of type 2 diabetes in China. Chin J Endocrinol Metab,2014,30(10):893-942.

    5 Wernicke JF, Pritchett YL, D’Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology, 2006,67(8):1411-1420.

    6 Sadosky A, Schaefer C, Mann R, et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey. Diabetes Metab Syndr Obes,2013(6):79-92.

    7 Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev,2014(2):CD009122.

    8 Li Ping, Ma Jianhua, Gao Jialin, et al. Clinical efficacy and safety of epalrestat in diabetic neuropathy-A multicenter randomized controlled clinical trial. Chin J Endocrinol Metab,2015,31(9):743-747.

    9 Pang GM, Zhu P, Han JT, et al. Clinical research on treatment of 60 patients with Diabetic peripheral neuropathy by Jiangtang Tongluo tablets. Clinical Journal of Chinese Medicine,2014,6(30):3-6.

    (Accepted: June 29, 2016)

    *Corresponding author: E-mail:liuchao@hotmail.com;Mobile phone:+86-258-5608735

    METHODS:Adopting stratified randomized and controlled design,82 patients with PDPN were assigned to two groups. Both groups continued conventional therapy. Epalrestat was administered to patients in both groups,and Shutangluo fang was given to patients in the treatment group.The treatment course lasted for 3 months. The changes before and after treatment of symptoms and signs, electrophysiological assessments were observed.

    RESULTS:The efficacy of the treatment group was better than the control group. The sensory nerve conduction velocity was significantly improved in the treatment group than the control group.

    CONCLUSIONS:Shutangluo fang is ef f ective on PDPN.

    猜你喜歡
    劉超
    老吳的拉面館
    Theoretical study of novel B-C-O compounds with non-diamond isoelectronic
    Removal of GaN film over AlGaN with inductively coupled BCl3/Ar atomic layer etch
    征程萬里,初心如一
    雷鋒(2021年12期)2021-04-12 00:57:22
    《站立式起跑》教學(xué)設(shè)計(jì)
    小數(shù)與小數(shù)點(diǎn)
    小數(shù)與小數(shù)點(diǎn)
    Design and experiment of the centrifugal pump impellers with twisted inlet vice blades *
    A simple method for estimating bed shear stress in smooth and vegetated compound channels*
    Support Effects on Thiophene Hydrodesulfurization over Co-Mo-Ni/Al2O3and Co-Mo-Ni/TiO2-Al2O3Catalysts*
    国产伦人伦偷精品视频| 欧美丝袜亚洲另类 | 国产又爽黄色视频| 国产日韩一区二区三区精品不卡| 老司机福利观看| 精品久久蜜臀av无| 一个人免费在线观看的高清视频| 亚洲色图av天堂| 丰满迷人的少妇在线观看| 欧美成狂野欧美在线观看| 国产亚洲欧美在线一区二区| 精品电影一区二区在线| 日本黄色视频三级网站网址 | 99精品在免费线老司机午夜| 黄色视频不卡| 国产不卡一卡二| 妹子高潮喷水视频| 多毛熟女@视频| 两人在一起打扑克的视频| 女人被狂操c到高潮| 狠狠婷婷综合久久久久久88av| 在线观看免费高清a一片| 精品无人区乱码1区二区| 80岁老熟妇乱子伦牲交| 久久久久久免费高清国产稀缺| 中文字幕精品免费在线观看视频| 一级片'在线观看视频| 99香蕉大伊视频| 一级a爱片免费观看的视频| 国产精品亚洲一级av第二区| 国产片内射在线| 精品国产一区二区久久| videosex国产| 久久久久精品人妻al黑| 国产三级黄色录像| 人人妻人人澡人人爽人人夜夜| 一级a爱片免费观看的视频| 又黄又爽又免费观看的视频| 一级毛片高清免费大全| 久久这里只有精品19| 亚洲av日韩精品久久久久久密| 成人免费观看视频高清| 欧美日本中文国产一区发布| 精品亚洲成a人片在线观看| 国产精品免费视频内射| 多毛熟女@视频| 国产精品久久视频播放| 亚洲精品美女久久av网站| 亚洲欧美色中文字幕在线| 免费在线观看完整版高清| 午夜福利,免费看| 国产精品香港三级国产av潘金莲| 国产免费男女视频| 亚洲免费av在线视频| 国产成人精品久久二区二区91| 亚洲第一青青草原| 国产主播在线观看一区二区| 老司机影院毛片| 一个人免费在线观看的高清视频| 在线免费观看的www视频| 热re99久久国产66热| 精品午夜福利视频在线观看一区| 大型av网站在线播放| 久久精品人人爽人人爽视色| 国产xxxxx性猛交| 国产免费av片在线观看野外av| 中文字幕人妻丝袜一区二区| 午夜影院日韩av| 国产乱人伦免费视频| 亚洲精品中文字幕在线视频| 好男人电影高清在线观看| 久久影院123| 十八禁人妻一区二区| 国产成人影院久久av| 一二三四社区在线视频社区8| 亚洲成人免费电影在线观看| 两个人免费观看高清视频| 一级片免费观看大全| 女警被强在线播放| 精品午夜福利视频在线观看一区| 国产成人免费观看mmmm| 黑丝袜美女国产一区| 亚洲精品一二三| 国产91精品成人一区二区三区| 国产精品影院久久| 侵犯人妻中文字幕一二三四区| 建设人人有责人人尽责人人享有的| 成人特级黄色片久久久久久久| 亚洲av成人不卡在线观看播放网| 国产野战对白在线观看| 午夜福利视频在线观看免费| 亚洲熟女毛片儿| 99久久99久久久精品蜜桃| 午夜免费鲁丝| 午夜免费鲁丝| 国产高清国产精品国产三级| 久久国产精品人妻蜜桃| 91精品国产国语对白视频| 老司机亚洲免费影院| 一边摸一边抽搐一进一出视频| 中文字幕最新亚洲高清| 一进一出抽搐动态| а√天堂www在线а√下载 | 国产国语露脸激情在线看| 国产国语露脸激情在线看| 中文字幕色久视频| 高清av免费在线| 人人澡人人妻人| 一区在线观看完整版| 久久精品91无色码中文字幕| 欧美精品一区二区免费开放| 久久精品91无色码中文字幕| 高清毛片免费观看视频网站 | 国产欧美日韩一区二区三区在线| 亚洲中文av在线| 精品无人区乱码1区二区| 欧美乱码精品一区二区三区| 亚洲片人在线观看| 欧美成狂野欧美在线观看| 精品国产乱子伦一区二区三区| 建设人人有责人人尽责人人享有的| 女人高潮潮喷娇喘18禁视频| 久久久久久久国产电影| 欧美日韩国产mv在线观看视频| 怎么达到女性高潮| 亚洲欧洲精品一区二区精品久久久| 欧美日韩福利视频一区二区| 中文欧美无线码| 亚洲精华国产精华精| 国产欧美日韩一区二区精品| 少妇猛男粗大的猛烈进出视频| av线在线观看网站| 亚洲成av片中文字幕在线观看| 国产精品自产拍在线观看55亚洲 | 黄片大片在线免费观看| 大陆偷拍与自拍| 国产男女超爽视频在线观看| 19禁男女啪啪无遮挡网站| 亚洲精品一二三| 欧美午夜高清在线| 精品乱码久久久久久99久播| 在线观看日韩欧美| 成年人午夜在线观看视频| 色在线成人网| 80岁老熟妇乱子伦牲交| 亚洲片人在线观看| 国产精品久久久人人做人人爽| 国产xxxxx性猛交| 人妻 亚洲 视频| 捣出白浆h1v1| 狠狠婷婷综合久久久久久88av| 男女免费视频国产| 国产精品一区二区在线观看99| 国产成人精品无人区| 国产成人一区二区三区免费视频网站| 老司机亚洲免费影院| 久久国产乱子伦精品免费另类| 一本一本久久a久久精品综合妖精| 99在线人妻在线中文字幕 | 视频在线观看一区二区三区| 欧美日韩乱码在线| 国产精品九九99| 天堂动漫精品| 热99久久久久精品小说推荐| 欧美黄色片欧美黄色片| 久久久精品国产亚洲av高清涩受| 国产精品免费视频内射| 国产精品国产av在线观看| 国产精品一区二区在线观看99| 亚洲av日韩在线播放| 亚洲av电影在线进入| 91麻豆精品激情在线观看国产 | 人妻丰满熟妇av一区二区三区 | 国产精品一区二区在线不卡| 可以免费在线观看a视频的电影网站| 欧美一级毛片孕妇| 黄片播放在线免费| 人人澡人人妻人| 久久人人爽av亚洲精品天堂| 咕卡用的链子| 精品国产国语对白av| 老熟妇乱子伦视频在线观看| 午夜福利影视在线免费观看| 又紧又爽又黄一区二区| 天天躁狠狠躁夜夜躁狠狠躁| 高清视频免费观看一区二区| 成人亚洲精品一区在线观看| 香蕉丝袜av| 亚洲国产精品一区二区三区在线| 久久性视频一级片| 两性夫妻黄色片| 成人手机av| 香蕉丝袜av| 最近最新中文字幕大全免费视频| 18禁国产床啪视频网站| 男女床上黄色一级片免费看| 日韩欧美三级三区| 午夜亚洲福利在线播放| 欧美久久黑人一区二区| 日本欧美视频一区| 亚洲人成电影观看| 国产精品欧美亚洲77777| 少妇猛男粗大的猛烈进出视频| 欧美乱码精品一区二区三区| 久久 成人 亚洲| 看黄色毛片网站| 久热爱精品视频在线9| 老司机靠b影院| 极品少妇高潮喷水抽搐| 亚洲精品在线观看二区| 欧美激情 高清一区二区三区| 热99re8久久精品国产| a级毛片黄视频| a级片在线免费高清观看视频| 免费人成视频x8x8入口观看| 久久这里只有精品19| 黄色丝袜av网址大全| 一级毛片女人18水好多| 无限看片的www在线观看| 成人av一区二区三区在线看| 飞空精品影院首页| 亚洲国产精品sss在线观看 | 女同久久另类99精品国产91| 国产一区二区三区在线臀色熟女 | 国产激情久久老熟女| 午夜免费鲁丝| 亚洲欧美精品综合一区二区三区| 老熟女久久久| 亚洲美女黄片视频| 一区二区日韩欧美中文字幕| 欧美日韩亚洲综合一区二区三区_| 狠狠狠狠99中文字幕| 亚洲欧美一区二区三区黑人| 丝袜美腿诱惑在线| 日本一区二区免费在线视频| 黄色成人免费大全| 午夜亚洲福利在线播放| 看片在线看免费视频| 国产成人系列免费观看| 亚洲欧美一区二区三区黑人| 国产精品亚洲av一区麻豆| 黄片播放在线免费| 看免费av毛片| 亚洲午夜精品一区,二区,三区| 亚洲精品成人av观看孕妇| 男人舔女人的私密视频| av天堂在线播放| 天堂√8在线中文| cao死你这个sao货| 女人精品久久久久毛片| 999久久久精品免费观看国产| 国产精品av久久久久免费| 国产aⅴ精品一区二区三区波| videos熟女内射| 亚洲av熟女| 欧美另类亚洲清纯唯美| 岛国在线观看网站| 在线观看一区二区三区激情| 国产xxxxx性猛交| 亚洲精品一二三| 大陆偷拍与自拍| 日本一区二区免费在线视频| 欧美另类亚洲清纯唯美| 成人永久免费在线观看视频| 午夜精品国产一区二区电影| 久久中文看片网| 亚洲成a人片在线一区二区| 黄网站色视频无遮挡免费观看| 俄罗斯特黄特色一大片| 人人妻人人澡人人看| 亚洲成人手机| 国产99白浆流出| 国产成人欧美| av欧美777| 国产精品九九99| 国产欧美日韩综合在线一区二区| 日本vs欧美在线观看视频| 久久人妻av系列| 又黄又粗又硬又大视频| 三上悠亚av全集在线观看| 亚洲国产看品久久| 国产成人精品无人区| 搡老乐熟女国产| 天天躁狠狠躁夜夜躁狠狠躁| 亚洲人成伊人成综合网2020| 9热在线视频观看99| 国产一卡二卡三卡精品| 亚洲av第一区精品v没综合| x7x7x7水蜜桃| 久久久国产一区二区| 欧美国产精品一级二级三级| 中文字幕高清在线视频| 国产精品一区二区精品视频观看| 午夜视频精品福利| 丁香欧美五月| 国产精品一区二区在线观看99| 两人在一起打扑克的视频| 亚洲精品中文字幕在线视频| 桃红色精品国产亚洲av| 又紧又爽又黄一区二区| a级片在线免费高清观看视频| 亚洲熟女精品中文字幕| 亚洲色图综合在线观看| 欧美成人午夜精品| 好男人电影高清在线观看| 一级a爱片免费观看的视频| 女人久久www免费人成看片| 久久99一区二区三区| 精品国产一区二区久久| 亚洲精品国产一区二区精华液| 下体分泌物呈黄色| 岛国毛片在线播放| 国产精品亚洲av一区麻豆| 曰老女人黄片| 少妇被粗大的猛进出69影院| 黄色视频不卡| 欧美在线一区亚洲| 老司机午夜十八禁免费视频| 国精品久久久久久国模美| 在线观看www视频免费| 巨乳人妻的诱惑在线观看| 男女免费视频国产| 精品久久蜜臀av无| 777久久人妻少妇嫩草av网站| 久久精品国产清高在天天线| 久久亚洲真实| 十分钟在线观看高清视频www| 免费av中文字幕在线| av不卡在线播放| 极品少妇高潮喷水抽搐| 啦啦啦 在线观看视频| 国产精华一区二区三区| 国产99久久九九免费精品| 激情视频va一区二区三区| 丰满的人妻完整版| 免费观看a级毛片全部| 9色porny在线观看| 看片在线看免费视频| 亚洲欧美精品综合一区二区三区| 亚洲国产毛片av蜜桃av| 精品久久久久久久毛片微露脸| 国产成人影院久久av| www.熟女人妻精品国产| www日本在线高清视频| 搡老岳熟女国产| 精品福利永久在线观看| 一级毛片精品| 亚洲全国av大片| 在线观看一区二区三区激情| 久久国产精品大桥未久av| 国产极品粉嫩免费观看在线| 精品一区二区三区av网在线观看| 亚洲一区中文字幕在线| 丝瓜视频免费看黄片| 黄色视频,在线免费观看| 国产麻豆69| 一级毛片精品| 人妻一区二区av| 国产精品久久电影中文字幕 | 可以免费在线观看a视频的电影网站| 国产精品乱码一区二三区的特点 | 亚洲精华国产精华精| √禁漫天堂资源中文www| 下体分泌物呈黄色| 午夜免费成人在线视频| 亚洲av第一区精品v没综合| 欧美一级毛片孕妇| 亚洲国产精品合色在线| 欧美老熟妇乱子伦牲交| 9色porny在线观看| 日本黄色日本黄色录像| 亚洲中文日韩欧美视频| 99精国产麻豆久久婷婷| 欧美日韩国产mv在线观看视频| 国产蜜桃级精品一区二区三区 | 手机成人av网站| videosex国产| 日本vs欧美在线观看视频| 国产亚洲精品久久久久久毛片 | 很黄的视频免费| 在线十欧美十亚洲十日本专区| 久久国产乱子伦精品免费另类| 欧美激情高清一区二区三区| 精品熟女少妇八av免费久了| 黑人操中国人逼视频| 一区二区日韩欧美中文字幕| 中文字幕色久视频| 成人国产一区最新在线观看| 一级片免费观看大全| 人人妻人人添人人爽欧美一区卜| 美女国产高潮福利片在线看| 人妻 亚洲 视频| 久久精品91无色码中文字幕| 国产99久久九九免费精品| 久久久久久免费高清国产稀缺| 99re6热这里在线精品视频| 日韩有码中文字幕| 一级毛片高清免费大全| 波多野结衣av一区二区av| 嫁个100分男人电影在线观看| 欧美 亚洲 国产 日韩一| 亚洲精品美女久久av网站| 少妇的丰满在线观看| 国产精品1区2区在线观看. | 日本黄色日本黄色录像| 久久久精品国产亚洲av高清涩受| 欧美性长视频在线观看| 天天躁夜夜躁狠狠躁躁| 在线天堂中文资源库| 久久精品亚洲av国产电影网| 精品第一国产精品| 国产日韩欧美亚洲二区| 久久久久久久精品吃奶| 欧美久久黑人一区二区| 人人妻,人人澡人人爽秒播| 一区二区三区精品91| 欧美日韩国产mv在线观看视频| 精品久久久久久,| 男女之事视频高清在线观看| 黑人猛操日本美女一级片| 免费看a级黄色片| 国产精品成人在线| 女性被躁到高潮视频| 精品久久久久久久毛片微露脸| √禁漫天堂资源中文www| 韩国精品一区二区三区| 十八禁人妻一区二区| 好看av亚洲va欧美ⅴa在| 久久狼人影院| 女人被狂操c到高潮| 欧美 日韩 精品 国产| 国产又色又爽无遮挡免费看| 香蕉国产在线看| 黑人操中国人逼视频| 国产不卡av网站在线观看| 成人三级做爰电影| 亚洲精品成人av观看孕妇| 亚洲av日韩精品久久久久久密| 久久久久精品国产欧美久久久| 久久国产精品人妻蜜桃| 亚洲在线自拍视频| 在线永久观看黄色视频| 免费在线观看亚洲国产| 飞空精品影院首页| 电影成人av| 亚洲自偷自拍图片 自拍| 91精品三级在线观看| 777米奇影视久久| 亚洲全国av大片| 亚洲欧美一区二区三区黑人| 正在播放国产对白刺激| 人人妻,人人澡人人爽秒播| tocl精华| 在线十欧美十亚洲十日本专区| 国产三级黄色录像| 久久久久精品国产欧美久久久| 欧美精品高潮呻吟av久久| 一级作爱视频免费观看| 黄网站色视频无遮挡免费观看| 俄罗斯特黄特色一大片| 啦啦啦视频在线资源免费观看| 国产免费av片在线观看野外av| 少妇的丰满在线观看| 亚洲专区中文字幕在线| 叶爱在线成人免费视频播放| 中文字幕最新亚洲高清| 涩涩av久久男人的天堂| 后天国语完整版免费观看| 欧美性长视频在线观看| av有码第一页| 怎么达到女性高潮| 黄片小视频在线播放| 亚洲综合色网址| 日韩制服丝袜自拍偷拍| cao死你这个sao货| 精品国内亚洲2022精品成人 | 午夜福利,免费看| 狂野欧美激情性xxxx| 韩国精品一区二区三区| 欧美亚洲 丝袜 人妻 在线| 又黄又爽又免费观看的视频| 精品国产一区二区三区久久久樱花| 久久热在线av| 80岁老熟妇乱子伦牲交| 人妻久久中文字幕网| av中文乱码字幕在线| 中文欧美无线码| 色老头精品视频在线观看| 国产精品.久久久| 黑人猛操日本美女一级片| 国产一区在线观看成人免费| 女人被狂操c到高潮| av线在线观看网站| 男人操女人黄网站| 亚洲欧美激情在线| 亚洲国产精品一区二区三区在线| 国产精品电影一区二区三区 | 成人手机av| 亚洲色图av天堂| 欧美日韩乱码在线| 咕卡用的链子| 午夜福利免费观看在线| 久久国产亚洲av麻豆专区| 少妇裸体淫交视频免费看高清 | 日韩人妻精品一区2区三区| 精品国内亚洲2022精品成人 | a级毛片在线看网站| 韩国av一区二区三区四区| 亚洲精品国产精品久久久不卡| 亚洲精品国产一区二区精华液| 精品电影一区二区在线| 午夜精品在线福利| 国产视频一区二区在线看| 久久久久久久精品吃奶| 欧美日韩国产mv在线观看视频| 久久人妻熟女aⅴ| 亚洲精品成人av观看孕妇| 精品国产一区二区久久| 久久狼人影院| 日韩欧美在线二视频 | 日韩一卡2卡3卡4卡2021年| 纯流量卡能插随身wifi吗| 成在线人永久免费视频| 国产1区2区3区精品| 免费在线观看完整版高清| 欧洲精品卡2卡3卡4卡5卡区| 日本欧美视频一区| 久久久国产成人精品二区 | 精品电影一区二区在线| 国产色视频综合| 亚洲熟女毛片儿| 国产精品久久视频播放| 精品国产亚洲在线| 亚洲成a人片在线一区二区| 91字幕亚洲| 色婷婷av一区二区三区视频| 亚洲美女黄片视频| 精品国产一区二区久久| 亚洲国产欧美日韩在线播放| 一边摸一边抽搐一进一小说 | 亚洲av日韩精品久久久久久密| 欧美久久黑人一区二区| 欧美激情 高清一区二区三区| 婷婷丁香在线五月| 搡老岳熟女国产| 免费不卡黄色视频| 纯流量卡能插随身wifi吗| 如日韩欧美国产精品一区二区三区| 国产亚洲精品久久久久久毛片 | 香蕉久久夜色| 国产亚洲精品久久久久5区| 色婷婷久久久亚洲欧美| 久久久久久久精品吃奶| 亚洲色图av天堂| 色精品久久人妻99蜜桃| 日韩免费高清中文字幕av| 国产男女超爽视频在线观看| 欧美乱码精品一区二区三区| 国产一区二区三区在线臀色熟女 | xxx96com| 午夜福利一区二区在线看| 久久久久国产一级毛片高清牌| 搡老岳熟女国产| 国产男女内射视频| 国产又爽黄色视频| 亚洲第一欧美日韩一区二区三区| 美女午夜性视频免费| 国产精品 欧美亚洲| 久久精品国产清高在天天线| 久久热在线av| 亚洲久久久国产精品| 精品国内亚洲2022精品成人 | 欧美亚洲 丝袜 人妻 在线| 黄色 视频免费看| 久久性视频一级片| 久久久久久人人人人人| 99久久国产精品久久久| 久久久久久久国产电影| av福利片在线| 亚洲伊人色综图| 国产97色在线日韩免费| 国产在线观看jvid| 黄色丝袜av网址大全| 男女床上黄色一级片免费看| 一级毛片高清免费大全| 亚洲九九香蕉| 不卡av一区二区三区| 精品免费久久久久久久清纯 | 成人免费观看视频高清| 欧美乱码精品一区二区三区| 在线看a的网站| 色婷婷久久久亚洲欧美| 中国美女看黄片| 丰满饥渴人妻一区二区三| 国产熟女午夜一区二区三区| 日本五十路高清| 精品欧美一区二区三区在线| 久久精品熟女亚洲av麻豆精品| 91大片在线观看| 黄频高清免费视频| 亚洲全国av大片| 丰满迷人的少妇在线观看| 久久99一区二区三区| av线在线观看网站| 亚洲精品国产一区二区精华液| 亚洲av美国av| 天天躁日日躁夜夜躁夜夜| 交换朋友夫妻互换小说| 国产99白浆流出| 久久精品成人免费网站| 精品国产亚洲在线| 久久久精品国产亚洲av高清涩受| 国产精品久久久av美女十八| 国产成人啪精品午夜网站| 亚洲精品一二三|